Coherus Oncology, Inc. (CHRS) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 154.50M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 154.50M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 154.50M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 154.50M | (m) | (m) |
| 2026-03-31 | 154.25M | (m) | (m) |
| 2025-12-31 | 149.89M | (m) | (m) |
| 2025-09-30 | 120.87M | (m) | (m) |
| 2025-06-30 | 116.23M | (m) | (m) |
| 2025-03-31 | 115.93M | (m) | (m) |
| 2024-12-31 | 115.90M | (m) | (m) |
| 2024-09-30 | 115.21M | (m) | (m) |
| 2024-06-30 | 115.21M | (m) | (m) |
| 2024-03-31 | 114.73M | (m) | (m) |
| 2023-12-31 | 112.71M | (m) | (m) |
| 2023-09-30 | 111.36M | (m) | (m) |
| 2023-06-30 | 94.47M | (m) | (m) |
| 2023-03-31 | 80.55M | (m) | (m) |
| 2022-12-31 | 79.61M | (m) | (m) |
| 2022-09-30 | 77.78M | (m) | (m) |
| 2022-06-30 | 77.72M | (m) | (m) |
| 2022-03-31 | 77.42M | (m) | (m) |
| 2021-12-31 | 77.28M | (m) | (m) |
| 2021-09-30 | 76.79M | (m) | (m) |
| 2021-06-30 | 76.48M | (m) | (m) |
| 2021-03-31 | 75.75M | (m) | (m) |
| 2020-12-31 | 72.79M | (m) | (m) |
| 2020-09-30 | 72.05M | (m) | (m) |
| 2020-06-30 | 71.47M | (m) | (m) |
| 2020-03-31 | 70.91M | (m) | (m) |
| 2019-12-31 | 70.62M | (m) | (m) |
| 2019-09-30 | 70.13M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |